News & Impact

You are here

News Across the Institute

Showing 25 - 30 of 138 total
Gibson Team in the Lab
NEWS: 
In the Media
Media Outlet: 
CNN Health
Benfotiamine and Cognitive Decline in Alzheimer's Disease, a small exploratory clinical trial, conducted by Dr. Gary E. Gibson’s laboratory at the Burke Neurological Institute is listed in CNN Health’s article on ”Top 2020 health stories you may have missed because of Covid-19” under Advances in Alzheimer’s.
Photo of Elizabeth
NEWS: 
Article

Elizabeth J. McCormack passed away peacefully at her home in New York City on Friday, December 4, 2020. She was 98 years old. 

Photo of Gibson Lab
NEWS: 
Article
A small exploratory clinical trial conducted by Dr. Gary E. Gibson’s laboratory at the Burke Neurological Institute in collaboration with physicians at the Burke Rehabilitation Hospital, suggests that Benfotiamine is safe and potentially efficacious in improving cognitive outcomes among people living with Mild Cognitive Impairment and mild Alzheimer’s disease (AD).
Photo of Dianna and Thulani
NEWS: 
Article
On Wednesday, November 18, 2020, Dr. Dianna Willis spoke about life of a scientist to children of the Kliptown Youth Program in South Africa, an educational program that helps boost academic excellence among very disadvantaged children.
Zhong Lab returning to lab
NEWS: 
Article
We are proud to be a strong team dedicated to spinal cord injury research, and proud to embark on our first phase I clinical trial soon.
Prusky Lab members 6 feet apart
NEWS: 
Article
Very recently, the Prusky Lab has resumed limited clinical studies on children at Blythedale Children’s Hospital and adults at Burke Neurological Institute. “I am most proud of lab member’s ability to adapt to the peculiar circumstances they have found themselves in, and make outstanding progress.,” shared Dr. Glen Prusky.